Willig, J. H., Aban, I., Nevin, C. R., Ye, J., Raper, J. L., McKinnel, J. A., . . . Saag, M. S. (2010). Darunavir Outcomes Study: Comparative Effectiveness of Virologic Suppression, Regimen Durability, and Discontinuation Reasons for Three-Class Experienced Patients at 48 Weeks. Mary Ann Liebert, Inc.
Chicago Style CitationWillig, James H., et al. Darunavir Outcomes Study: Comparative Effectiveness of Virologic Suppression, Regimen Durability, and Discontinuation Reasons for Three-Class Experienced Patients At 48 Weeks. Mary Ann Liebert, Inc, 2010.
Cita MLAWillig, James H., et al. Darunavir Outcomes Study: Comparative Effectiveness of Virologic Suppression, Regimen Durability, and Discontinuation Reasons for Three-Class Experienced Patients At 48 Weeks. Mary Ann Liebert, Inc, 2010.